Similar stories
1 outlet
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition
finance.yahoo.com
14.09.2026
Related stories
With the Anthropic IPO, the devil is in the details
Sorry investors, but there’s no such thing as an early ‘Santa Claus rally.’ Here’s when the real gains typically happen.
The house, the kids’ college and the raise: Where people in their 30s and 40s go wrong
McDonald’s new bet on chicken hits a snag as franchisees say the birds are too big
These energy stocks are poised to profit from an imminent AI power crunch
Trump administration illegally fired Maurene Comey, judge rules